The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance

George E. Durán(Palo Alto University), Branimir I. Šikić(Stanford Medicine)

PLoS ONE

January 22, 2019

10.1371/journal.pone.0210879

Cited by 4

Related Papers

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

|Journal of Clinical Oncology|2019|590

Functional Network Analysis Reveals Extended Gliomagenesis Pathway Maps and Three Novel MYC-Interacting Genes in Human Gliomas

|Cancer Research|2005|312

Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition

|British Journal of Cancer|2017|47